Dr. Sarit Assouline
May 2017Research at the Lady Davis Institute

Promising therapy for relapsed patients with aggressive form of lymphoma

A unique phase 2 clinical trial, led by researchers in the Segal Cancer Centre at the JGH, has resulted in a remission of diffuse large B-cell lymphoma for patients who have relapsed and have a particularly dire prognosis.

READ MORE →
Dr. Leon van Kempen, Chief Operating Officer of the Dubrovsky Molecular Pathology Centre at the JGH, drops into The Auxiliary’s Fall Fair and Raffle, whose proceeds are being used to purchase a fluorescence microscope for the Centre. Joining Dr. van Kempen are Auxiliary Co-Presidents Beatrice Lewis (left) and Reisa Lerner (right), and Auxiliary Director Nancy Rubin. The Fall Fair and Raffle is co-chaired by Linny Blauer and Phyllis Karper.
April 2016Auxiliary

The Auxiliary … it’s about caring

As The Auxiliary approaches its 80th anniversary, it continues to gain strength and vitality through the dedication, effort, energy, talent and creativity of its legion of volunteers.

READ MORE →
Dr. Christoph Borchers
Research at the Lady Davis InstituteSeptember 2015

Pioneering effort to apply novel biotechnology to cancer research

The effort to find new biomarkers for cancer has received a major boost with the recent arrival at Lady Davis Institute of Dr. Christoph Borchers and the development of the first pan-Canadian proteomics program.

READ MORE →
Dr Christoph Borchers
Research at the Lady Davis InstituteSpring 2015

Partnership supports cancer-fighting
power of protein analysis

Dr. Christoph Borchers has established the first pan-Canadian proteomics program, custom-tailoring cancer treatments to meet the needs of individual patients

READ MORE →